PA000310-030108C01: IL-1ra Monoclonal Antibody
Mouse Monoclonal Antibody;
Applications: Indirect ELISA;
Reactivity: Human;
Clone No: KT6;
Isotype: Mouse IgG1.BP000144-C033: Recombinant Human Interleukin-1 Receptor Antagonist Protein (IL-1RA)
Source: E. coli-derived.
The ED50 as determined by the dose-dependant inhibition of IL-1 stimulation of D10S cells was found to be 0.5 ug/ml, corresponding to a Specific Activity of 2.0 x 106 IU/mg.
Purity: > 95% by RP-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).BP000144-CYT-203: Recombinant Human Interleukin-1 Receptor Antagonist Protein (IL-1RA)
Source: E. coli-derived.
The ED50 as determined by the dose-dependant inhibition of IL-1 stimulation of D10S cells was found to be 0.5 ug/ml corresponding to a Specific Activity of 2,000,000 IU/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000144-CYT-481: Recombinant Human Interleukin-1 Receptor Antagonist Protein (IL-1RA), His Tag
Source: E. coli-derived.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000144-CYT-658: Recombinant Mouse Interleukin-1 Receptor Antagonist Protein (IL-1RA) Protein
Source: E. coli-derived.
The mouse IL-1Ra is capable of inhibiting IL-1-alpha activity in helper T cell line D10.G4.1.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000144-CYT-136: Recombinant Mouse Interleukin-1 Receptor Antagonist Protein (IL-1RA), His Tag
Source: E. coli-derived.
Purity: > 95% by SDS-PAGEBP000144-CYT-152: Recombinant Rat Interleukin-1 Receptor Antagonist Protein (IL-1RA)
Source: E. coli-derived.
Fully biologically active when compared to standard. Measured by its ability to inhibit IL1-dependent proliferation in D10.G4.1 mouse helper T cells. The ED50 for this effect is typically 30-150 ng/ml (corresponding to a specific activity of 6,667-33,334 units/mg ) in the presence of 50 pg/ml of rrIL1.
Purity: > 95.0% by SDS-PAGE.